154 related articles for article (PubMed ID: 23689989)
1. IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Sato M; Kato N; Tateishi R; Muroyama R; Kowatari N; Li W; Goto K; Otsuka M; Shiina S; Yoshida H; Omata M; Koike K
J Gastroenterol; 2014 Apr; 49(4):748-54. PubMed ID: 23689989
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy.
Chang KC; Ye YH; Wu CK; Lin MT; Tsai MC; Tseng PL; Hu TH
J Formos Med Assoc; 2018 Nov; 117(11):1011-1018. PubMed ID: 29254684
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study.
Buivydiene A; Liakina V; Kashuba E; Norkuniene J; Jokubauskiene S; Gineikiene E; Valantinas J
Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344298
[No Abstract] [Full Text] [Related]
5. Risk of hepatocellular carcinoma development in cases of hepatitis C treated by long-term, low-dose PEG-IFNα-2a.
Hagiwara S; Sakurai T; Takita M; Ueshima K; Minami Y; Inoue T; Yada N; Kitai S; Nagai T; Hayaishi S; Arizumi T; Nishida N; Kudo M
Dig Dis; 2012; 30(6):561-7. PubMed ID: 23258095
[TBL] [Abstract][Full Text] [Related]
6. IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients.
Khalil FO; Alsebaey A; Kasemy ZA; Abdelmageed SM; Bedair HM; Abdelsattar S
Expert Rev Anti Infect Ther; 2022 Jan; 20(1):121-129. PubMed ID: 34047252
[TBL] [Abstract][Full Text] [Related]
7. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
[TBL] [Abstract][Full Text] [Related]
9. Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.
Eurich D; Boas-Knoop S; Bahra M; Neuhaus R; Somasundaram R; Neuhaus P; Neumann U; Seehofer D
Transplantation; 2012 Mar; 93(6):644-9. PubMed ID: 22411462
[TBL] [Abstract][Full Text] [Related]
10. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Asahina Y; Tsuchiya K; Nishimura T; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Enomoto N; Nakagawa M; Kakinuma S; Watanabe M; Izumi N
J Gastroenterol; 2014 Jul; 49(7):1152-62. PubMed ID: 23860735
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.
Lee K; Sinn DH; Gwak GY; Cho HC; Jung SH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Gut Liver; 2016 Sep; 10(5):796-802. PubMed ID: 27114418
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma.
Ren S; Lu J; Du X; Huang Y; Ma L; Huo H; Chen X; Wei L
Cancer Immunol Immunother; 2012 Sep; 61(9):1433-9. PubMed ID: 22310928
[TBL] [Abstract][Full Text] [Related]
14. Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection.
Joshita S; Umemura T; Katsuyama Y; Ichikawa Y; Kimura T; Morita S; Kamijo A; Komatsu M; Ichijo T; Matsumoto A; Yoshizawa K; Kamijo N; Ota M; Tanaka E
Hum Immunol; 2012 Mar; 73(3):298-300. PubMed ID: 22245236
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C.
Mah YH; Liu CH; Chen CL; Tseng TC; Liu CJ; Chen PJ; Chen DS; Kao JH
J Formos Med Assoc; 2016 Nov; 115(11):953-960. PubMed ID: 27751759
[TBL] [Abstract][Full Text] [Related]
17. Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C.
Hodo Y; Honda M; Tanaka A; Nomura Y; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Sakai A; Sasaki M; Nakanuma Y; Moriyama M; Kaneko S
Clin Cancer Res; 2013 Apr; 19(7):1827-37. PubMed ID: 23426277
[TBL] [Abstract][Full Text] [Related]
18. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796
[TBL] [Abstract][Full Text] [Related]
19. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
[TBL] [Abstract][Full Text] [Related]
20. IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.
Bochud PY; Bibert S; Kutalik Z; Patin E; Guergnon J; Nalpas B; Goossens N; Kuske L; Müllhaupt B; Gerlach T; Heim MH; Moradpour D; Cerny A; Malinverni R; Regenass S; Dollenmaier G; Hirsch H; Martinetti G; Gorgiewski M; Bourlière M; Poynard T; Theodorou I; Abel L; Pol S; Dufour JF; Negro F; ;
Hepatology; 2012 Feb; 55(2):384-94. PubMed ID: 22180014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]